FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1820638139> ?p ?o ?g. }

• W1820638139 endingPage "795" @default.
• W1820638139 startingPage "784" @default.
• W1820638139 abstract "Aim/Objective: Increase in incidences of pneumonia due to multi-drug resistant methicillin resistant Staphylococcus aureus (MRSA) in both community and health care settings is of great concern globally. Present study aims to retrospectively analyze the efficacy of new fixed dose combination with antibiotic adjuvant entity (FDC) in comparison with vancomycin to treat patients with multi-drug resistant MRSA pneumonia. Materials and Methods: During this retrospective study, case sheets of patients who were treated for MRSA pneumonia with vancomycin or fixed dose combination of vancomycin + ceftriaxone + adjuvant (FDC) between 20 March 2010 to 20 October 2014 at tertiary care center, were analyzed. Various demographic features, antibiotic therapy, length of treatment duration and the resulting efficacy were evaluated. Microbiological success was measured in terms of bacterial eradication, while clinical success was monitored in terms of complete omission of systemic signs and symptoms. Results: Among 136 patients analyzed, 113 cases were having positive culture for MRSA, and hence were further analyzed. Out of these 113 patients, empirical treatment with vancomycin was given in 59 patients and 54 patients were treated with FDC empirically. After initial culture reports, 22 patients showing resistance to vancomycin were shifted to FDC. Amidst all the patients, 24 (64.86%) of 37 from vancomycin group and 62 (81.57%) of 76 from FDC group achieved clinical success. 9 patients out of these failure cases were cured with FDC + colistin combination therapy. Failure rates in FDC treated patients were significantly low (6.57%) as compared to vancomycin group (13.51%). Conclusion: For the treatment of different types of multi-drug resistant MRSA pneumonia, the empirical intravenous FDC therapy was safe and well tolerated with higher efficacy than vancomycin. Most of the vancomycin failure cases responded to FDC therapy and were cured. This retrospective study also concludes that an alternative option of FDC + colistin is safe and effective to treat the patients which fail to respond to FDC monotherapy." @default.
• W1820638139 created "2016-06-24" @default.
• W1820638139 creator A5069823941 @default.
• W1820638139 date "2015-01-01" @default.
• W1820638139 modified "2023-10-18" @default.
• W1820638139 title "Management of Multi-Drug Resistant Methicillin Resistant <i>Staphylococcus aureus</i> Induced Pneumonia with New Antibiotic Adjuvant Entity: A Retrospective Study" @default.
• W1820638139 cites W123011465 @default.
• W1820638139 cites W124743390 @default.
• W1820638139 cites W1555403508 @default.
• W1820638139 cites W1963015968 @default.
• W1820638139 cites W1970085091 @default.
• W1820638139 cites W1970492397 @default.
• W1820638139 cites W1980904261 @default.
• W1820638139 cites W1986702514 @default.
• W1820638139 cites W2009977515 @default.
• W1820638139 cites W2014116260 @default.
• W1820638139 cites W2020188983 @default.
• W1820638139 cites W2022869902 @default.
• W1820638139 cites W2024937400 @default.
• W1820638139 cites W2026427487 @default.
• W1820638139 cites W2026775668 @default.
• W1820638139 cites W2029896244 @default.
• W1820638139 cites W203614530 @default.
• W1820638139 cites W2046450837 @default.
• W1820638139 cites W2054533199 @default.
• W1820638139 cites W2062945788 @default.
• W1820638139 cites W2063380036 @default.
• W1820638139 cites W2081422800 @default.
• W1820638139 cites W2082816719 @default.
• W1820638139 cites W2097343153 @default.
• W1820638139 cites W2100666674 @default.
• W1820638139 cites W2100693239 @default.
• W1820638139 cites W2108433768 @default.
• W1820638139 cites W2108934165 @default.
• W1820638139 cites W2111610806 @default.
• W1820638139 cites W2116816874 @default.
• W1820638139 cites W2117173742 @default.
• W1820638139 cites W2118348120 @default.
• W1820638139 cites W2124161201 @default.
• W1820638139 cites W2125066910 @default.
• W1820638139 cites W2135191756 @default.
• W1820638139 cites W2137175695 @default.
• W1820638139 cites W2144258933 @default.
• W1820638139 cites W2145764069 @default.
• W1820638139 cites W2151958462 @default.
• W1820638139 cites W2152344036 @default.
• W1820638139 cites W2159145150 @default.
• W1820638139 cites W2166425259 @default.
• W1820638139 cites W2167351407 @default.
• W1820638139 cites W2170219835 @default.
• W1820638139 cites W2186550856 @default.
• W1820638139 cites W2187790984 @default.
• W1820638139 cites W2276443311 @default.
• W1820638139 cites W2318653171 @default.
• W1820638139 cites W2336324580 @default.
• W1820638139 doi "https://doi.org/10.4236/ijcm.2015.610104" @default.
• W1820638139 hasPublicationYear "2015" @default.
• W1820638139 type Work @default.
• W1820638139 sameAs 1820638139 @default.
• W1820638139 citedByCount "0" @default.
• W1820638139 crossrefType "journal-article" @default.
• W1820638139 hasAuthorship W1820638139A5069823941 @default.
• W1820638139 hasBestOaLocation W18206381391 @default.
• W1820638139 hasConcept C126322002 @default.
• W1820638139 hasConcept C141071460 @default.
• W1820638139 hasConcept C167135981 @default.
• W1820638139 hasConcept C2777052132 @default.
• W1820638139 hasConcept C2777914695 @default.
• W1820638139 hasConcept C2778980435 @default.
• W1820638139 hasConcept C2779489039 @default.
• W1820638139 hasConcept C501593827 @default.
• W1820638139 hasConcept C523546767 @default.
• W1820638139 hasConcept C54355233 @default.
• W1820638139 hasConcept C71924100 @default.
• W1820638139 hasConcept C86803240 @default.
• W1820638139 hasConcept C89423630 @default.
• W1820638139 hasConceptScore W1820638139C126322002 @default.
• W1820638139 hasConceptScore W1820638139C141071460 @default.
• W1820638139 hasConceptScore W1820638139C167135981 @default.
• W1820638139 hasConceptScore W1820638139C2777052132 @default.
• W1820638139 hasConceptScore W1820638139C2777914695 @default.
• W1820638139 hasConceptScore W1820638139C2778980435 @default.
• W1820638139 hasConceptScore W1820638139C2779489039 @default.
• W1820638139 hasConceptScore W1820638139C501593827 @default.
• W1820638139 hasConceptScore W1820638139C523546767 @default.
• W1820638139 hasConceptScore W1820638139C54355233 @default.
• W1820638139 hasConceptScore W1820638139C71924100 @default.
• W1820638139 hasConceptScore W1820638139C86803240 @default.
• W1820638139 hasConceptScore W1820638139C89423630 @default.
• W1820638139 hasIssue "10" @default.
• W1820638139 hasLocation W18206381391 @default.
• W1820638139 hasOpenAccess W1820638139 @default.
• W1820638139 hasPrimaryLocation W18206381391 @default.
• W1820638139 hasRelatedWork W2073702194 @default.
• W1820638139 hasRelatedWork W2141365771 @default.
• W1820638139 hasRelatedWork W2343410727 @default.
• W1820638139 hasRelatedWork W2363270915 @default.
• W1820638139 hasRelatedWork W2368464637 @default.

• next